Fundraising Fox
One Zyme
Founded 2025 · 7 employees on LinkedIn · 5 known investors
Find your way into One Zyme
875 people in our graph can introduce you to the One Zyme team.
Sign up to see every warm intro you have to One Zyme
- Paths you didn't know you had: your email and LinkedIn already hold routes to the One Zyme team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
One Zyme is an AI-native intelligence platform that aggregates scientific, clinical, regulatory, funding, patent, deal, and conference signals into a shared knowledge graph for life sciences teams. It provides AI agents and nine intelligence workflows serving business development, competitive intelligence, R&D, commercial, and biopharma vendor teams across the pharma and biotech industry.
Founders & leadership
One Zyme was founded in 2025 by Aaron Michel.
Investors · 5
How we know: Esplanade Ventures's portfolio page · Not right? Tell us
How we know: Newfund Capital's portfolio page · Not right? Tell us
How we know: Service Provider Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does One Zyme do?
- One Zyme is an AI-native intelligence platform that aggregates scientific, clinical, regulatory, funding, patent, deal, and conference signals into a shared knowledge graph for life sciences teams. It provides AI agents and nine intelligence workflows serving business development, competitive intelligence, R&D, commercial, and biopharma vendor teams across the pharma and biotech industry.
- Who founded One Zyme?
- One Zyme was founded by Aaron Michel in 2025.
- Who are One Zyme's investors?
- One Zyme's investors include Esplanade Ventures, Invariantes Fund, Newfund Capital, Service Provider Capital, TMV.